KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Co-Diagnostics (CODX) Non Operating Investment Income (2022 - 2025)

Historic Non Operating Investment Income for Co-Diagnostics (CODX) over the last 4 years, with Q1 2025 value amounting to $717067.0.

  • Co-Diagnostics' Non Operating Investment Income rose 5925.62% to $717067.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $862831.0, marking a year-over-year increase of 7080.05%. This contributed to the annual value of $714876.0 for FY2024, which is 3457.0% down from last year.
  • Per Co-Diagnostics' latest filing, its Non Operating Investment Income stood at $717067.0 for Q1 2025, which was up 5925.62% from $450260.0 recorded in Q1 2024.
  • Co-Diagnostics' Non Operating Investment Income's 5-year high stood at $3.4 million during Q1 2022, with a 5-year trough of -$444792.0 in Q4 2023.
  • In the last 4 years, Co-Diagnostics' Non Operating Investment Income had a median value of $764944.5 in 2022 and averaged $1.0 million.
  • Its Non Operating Investment Income has fluctuated over the past 5 years, first crashed by 15422.98% in 2023, then soared by 5925.62% in 2025.
  • Quarter analysis of 4 years shows Co-Diagnostics' Non Operating Investment Income stood at $820198.0 in 2022, then plummeted by 154.23% to -$444792.0 in 2023, then soared by 201.23% to $450260.0 in 2024, then surged by 59.26% to $717067.0 in 2025.
  • Its Non Operating Investment Income was $717067.0 in Q1 2025, compared to $450260.0 in Q1 2024 and -$444792.0 in Q4 2023.